Flagged as a potential pandemic-causing virus, this is the first Marburg vaccine to move into Phase 2 human trials. ... uses an adenovirus vector to deliver a Marburg glycoprotein.

An experimental vaccine for Marburg virus—a deadly cousin of the infectious agent that causes Ebola—can ... an adenovirus-vectored shot that expresses the Marburg virus (MARV) glycoprotein.

A deadly, Ebola-like virus called Marburg is currently causing an outbreak in Rwanda. The country declared an outbreak of Marburg virus disease on Sept. 27 and has reported 58 confirmed cases and ...

A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial.

An experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. genprowebdirectory Facebook Linkedin RSS Twitter Youtube ...

Marburg virus disease is spreading in Rwanda and has claimed 6 lives so far. Rwanda's Minister of Health, Sabin Nsanzimana, revealed that the victims and most of the infected are healthcare ...

A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine ...

Marburg virus disease has killed 11 people and sickened 25 others in Rwanda, which declared an outbreak on Sept. 27. Similar to Ebola, the rare but very severe illness can be fatal in up to 88% of ...

Rwanda is experiencing an outbreak of Marburg virus disease, resulting in six deaths, mainly among healthcare workers. The virus causes severe illness with symptoms like high fever and vomiting ...

Without treatment, Marburg can be fatal in up to 88% of people who fall ill with the disease. There are currently no approved vaccines or treatments specifically for this virus.